Skip to content
News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Fda Approval
December 22, 2025
Rybrevant (Amivantamab) Treatment of EGFR Positive Non-Small Cell Lung Cancer
Dr. C H Weaver MD
November 17, 2023
Truqap (capivasertib) in Breast Cancer
Dr. C H Weaver MD
November 16, 2023
Treatment of ROS1+ NSCLC with Augtyro (repotrectinib)
Dr. C H Weaver MD
October 25, 2023
Tibsovo for Treatment of Acute Myeloid Leukemia
Dr. C H Weaver MD
October 16, 2023
Treatment of Stage II Melanoma
Dr. C H Weaver MD
September 11, 2023
Welireg – Promising Addition to Treatment of Renal Cell Cancer
Dr. C H Weaver MD
August 28, 2023
Talvey (talquetamab) for Multiple Myeloma
Dr. C H Weaver MD
June 23, 2021
Elahere (mirvetuximab soravtansine)
Dr. C H Weaver MD
December 8, 2020
Tecvayli (Teclistamab) for the Treatment of Multiple Myeloma
Dr. C H Weaver MD
December 5, 2020
Magrolimab Anti-CD47 Monoclonal Antibody
Dr. C H Weaver MD
September 22, 2020
Gavreto Treatment for RET Fusion-Positive Non-Small Cell Lung Cancer
Dr. C H Weaver MD
July 2, 2020
Brukinsa BTK Inhibitor for CLL/SLL
Dr. C H Weaver MD
1
2
Next Page
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
